BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bucalo A, Rega F, Zangrilli A, Silvestri V, Valentini V, Scafetta G, Marraffa F, Grassi S, Rogante E, Piccolo A, Cucchiara S, Viola F, Bianchi L, Ottini L, Richetta A. Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers. Int J Mol Sci 2020;21:E7873. [PMID: 33114187 DOI: 10.3390/ijms21217873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cather JC, Young CT, Young MS, Cather JC. Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasis. Expert Opin Biol Ther 2021;21:983-90. [PMID: 34106794 DOI: 10.1080/14712598.2021.1931679] [Reference Citation Analysis]
2 Diamanti E, Föhr J, Papageorgiou A, Herbst M, Jahn S. Immunologie in der dermatologischen Praxis – wieviel, warum, wann? Aktuelle Dermatologie 2022;48:201-8. [DOI: 10.1055/a-1699-5440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Spencer EA, Dubinsky MC. Precision Medicine in Pediatric Inflammatory Bowel Disease. Pediatr Clin North Am 2021;68:1171-90. [PMID: 34736583 DOI: 10.1016/j.pcl.2021.07.011] [Reference Citation Analysis]
4 Bezzio C, Della Corte C, Vernero M, Di Luna I, Manes G, Saibeni S. Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations. Therap Adv Gastroenterol 2022;15:175628482211153. [DOI: 10.1177/17562848221115312] [Reference Citation Analysis]
5 Mercogliano MF, Bruni S, Mauro F, Elizalde PV, Schillaci R. Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy. Cancers (Basel) 2021;13:564. [PMID: 33540543 DOI: 10.3390/cancers13030564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Cyrenne BM, Parpia AS, Sibbald C. Paradoxical psoriasis in pediatric patients: A systematic review. Pediatr Dermatol 2021. [PMID: 34402108 DOI: 10.1111/pde.14712] [Reference Citation Analysis]